The distribution of disease stage was: stage I, 4. 4% (41 patients); stage II, sixteen. 1% (193 patients); stage III, 55. 8% (608 patients) and stage IV, 29. 6% (354) individuals. staging meant for risk description in non-metastatic NPC. Keywords: non-metastatic nasopharyngeal carcinoma (NPC), apolipoprotein A-I (ApoA-I), prognosis == ADVANTAGES == Nasopharyngeal carcinoma (NPC) is… Continue reading The distribution of disease stage was: stage I, 4